Effect of Age on the Success of DPC Using Bio-ceramic Materials in Cariously Exposed Teeth With Reversible Pulpitis
NCT ID: NCT06240169
Last Updated: 2024-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
174 participants
INTERVENTIONAL
2022-06-01
2024-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Rationale: - Preservation of pulp vitality is a critical factor in long-term tooth survival. In deep carious lesion with reversible pulpitis, vital pulp therapy procedures in the form of direct pulp capping(DPC)is more conservative treatment strategy, based on the premise that a biologically active material placed in direct contact with the pulp wound can determine the pulpal response and result in the development of a reparative hard tissue bridge to preserve pulp vitality. Patient's age may have a role in the survival rate after direct pulp capping and the role of the pulp capping material has been recognized as an important parameter for the success of treatment.
Research Question : Does age has any influence on the success of DPC procedure and is there any difference between MTA and Biodentine as DPC material in cariously exposed permanent teeth with reversible pulpitis? Aim \& Objectives- To evaluate the effect of age on success of Direct Pulp Capping, to evaluate the success of MTA and Biodentine as direct pulp capping agents.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcome of Direct Pulp Capping and Partial Pulpotomy in Reversible Pulpitis
NCT07300124
Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars
NCT06433297
Clinical Comparison of Vital Pulp Capping Restorative Protocols
NCT02635867
Clinical & Radiographical Evaluation of the Effect of Dycal & Biodentine in DPC in Primary Teeth
NCT02789423
Outcome of Pulpotomy With MTA and Biodentin in Permanent Teeth With Caries Exposure
NCT06913283
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Rationale: - Preservation of pulp vitality is a critical factor in long-term tooth survival. In deep carious lesion with reversible pulpitis, vital pulp therapy procedures in the form of direct pulp capping(DPC)is more conservative treatment strategy, based on the premise that a biologically active material placed in direct contact with the pulp wound can determine the pulpal response and result in the development of a reparative hard tissue bridge to preserve pulp vitality. Patient's age may have a role in the survival rate after direct pulp capping and the role of the pulp capping material has been recognized as an important parameter for the success of treatment.
Research Question : Does age has any influence on the success of DPC procedure and is there any difference between MTA and Biodentine as DPC material in cariously exposed permanent teeth with reversible pulpitis? Aim \& Objectives- To evaluate the effect of age on success of Direct Pulp Capping, to evaluate the success of MTA and Biodentine as direct pulp capping agents based on clinical and radiographic findings and assessment of post operative pain for 7 days post treatment.
Statistical method: - Data analysis by suitable statistical method.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DPC in AGE I with MTA
DPC using MTA in Age group I i.e. 18-40years.
DPC with MTA in AGEI
DPC using MTA in 18-40 years
DPC in AGE I with BD
DPC using BD in Age group I i.e. 18-40years.
DPC with BD in AGEI
DPC using BD in 18-40 years
DPC in AGE II with MTA
DPC using MTA in Age group II i.e. 41-60years
DPC with MTA in AGEII
DPC using MTA in 41-60Years
DPC in AGE II with BD
DPC using BD in Age group II i.e. 41-60years
DPC with BD in AGEII
DPC using BD in 41-60Years
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
DPC with MTA in AGEI
DPC using MTA in 18-40 years
DPC with BD in AGEI
DPC using BD in 18-40 years
DPC with MTA in AGEII
DPC using MTA in 41-60Years
DPC with BD in AGEII
DPC using BD in 41-60Years
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients falling in the age group of 18-60 years.
* Restorable permanent mandibular posterior teeth.
* Extremely deep caries penetrating the entire thickness of dentine and exhibiting signs and symptoms of reversible pulpitis.
* Teeth responding positively to cold test and electric pulp testing with no tenderness on percussion.
Exclusion Criteria
* Traumatic or mechanical exposure.
* No pulp exposure after caries excavation.
* Hemostasis not achieved within 10 mins.
* Teeth with irreversible pulpitis.
* Presence of periapical lesion or evidence of internal or external resorption, calcified canals, as assessed by radiographic examination.
* Patients with periodontal disease, swelling and sinus tract.
* Immunocompromised or pregnant patients, patients with any systemic disease, and a positive history of antibiotic use within 1 month and analgesic use within week before the treatment.
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Postgraduate Institute of Dental Sciences Rohtak
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sanjay Tewari
Role: PRINCIPAL_INVESTIGATOR
pgids rohtak
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PGIDS
Rohtak, Haryana, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Harshita Wadhwa
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.